The report "Biobanking Market by product type (Equipment (Incubators, Centrifuges, Alarm and Monitoring Systems, Temperature Control Systems, Others), Consumables), by sample type (Biological Fluids, Human Waste Products, Blood Products, Human Tissues, Cell Lines, Nucleic Acids), by application (Therapeutic Applications, Research Applications, Clinical Trials), by end-user (Pharmaceutical and Biopharmaceutical Companies, Clinical Research Organizations, Research Institutes, Others) - Global Forecasts to 2030"
The global biobanking market is projected to reach USD 43.8 billion in 2023, registering a Compound Annual Growth Rate (CAGR) of 6.3% during the forecast period 2024-2030. The growth of the market is majorly driven by the growing focus on mainstream precision medicine and the rise of genomic medicine/clinical genomics.
The process of gathering and preserving biological materials for use in research, biodiversity studies, and diagnostics is known as biobanking. Biobanks are essential to the advancement of personalized treatment, the upkeep and updating of age demographic datasets, and scientific research projects.
Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=22456
Competitive Dashboard:
The prominent key players operating in the global Biobanking market are Agilent Technologies Inc., Amgen Inc., Astrazeneca, Avantor Inc., Azenta Life Sciences, Biokryo Gmbh, Bruker Corp., Centogene N.V., Hamilton Co., Indivumed Gmbh, Merck Kgaa, Qiagen, Tecan Group Ltd., Thermo Fisher Scientific Inc.
Regional Overview:
The report also examines the current concerns and their Future Effects on the biobanking market by the region. The report covers all regions and countries, North America was the largest and Asia was the fastest-growing region in the biobanking market. The market has been segmented into numerous primary regions and a detailed evaluation of primary countries.
- North America (U.S., Canada)
- Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
- Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
- Middle East Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)
A Few Points from the Table of Contents –
1. Executive Summary
2. Global Biobanking Market Introduction
3. Global Biobanking Market Dynamics
4. Global Biobanking Market Analysis, 2019 - 2023 and Forecast 2024 – 2030
……………….
9. Global Biobanking Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10. North America Biobanking Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11. Europe Biobanking Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12. Asia Pacific (APAC) Biobanking Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13. Middle East and Africa (MEA) Biobanking Market 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
14. Latin America Biobanking Market 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
15. Competition Landscape
16. Research Methodology
17. Appendix and Abbreviations
Scope of The Report:
- The biobanking market research report includes historical data, trending features, and market growth estimates for the future.
- The qualitative and quantitative analysis of the market along with CAGR calculation for the forecast period.
- The biobanking market report helps to provide the best results for business enhancement and business growth.
- The report gives a comprehensive overview of both primary and secondary data.
- The biobanking market key players covered here to help them strengthen their place in the market.
About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to delivering more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.
Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.
Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747
